| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |